CASI Annual Accounts Payable
$4.44 M
+$1.15 M+34.93%
31 December 2023
Summary:
As of January 20, 2025, CASI annual accounts payable is $4.44 million, with the most recent change of +$1.15 million (+34.93%) on December 31, 2023. During the last 3 years, it has risen by +$1.18 million (+36.13%). CASI annual accounts payable is now -72.79% below its all-time high of $16.31 million, reached on December 31, 2001.CASI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Quarterly Accounts Payable
$1.76 M
+$972.00 K+122.73%
01 September 2024
Summary:
As of January 20, 2025, CASI quarterly accounts payable is $1.76 million, with the most recent change of +$972.00 thousand (+122.73%) on September 1, 2024. Over the past year, it has dropped by -$2.67 million (-60.25%). CASI quarterly accounts payable is now -89.18% below its all-time high of $16.31 million, reached on December 31, 2001.CASI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.9% | -60.3% |
| 3 y3 years | +36.1% | -60.3% |
| 5 y5 years | +358.5% | -60.3% |
CASI Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.6% | -75.4% | +202.6% |
| 5 y | 5-year | -13.2% | +99.6% | -75.4% | +202.6% |
| alltime | all time | -72.8% | +1002.6% | -89.2% | +400.7% |
CASI Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.76 M(+122.7%) |
| June 2024 | - | $792.00 K(+35.8%) |
| Mar 2024 | - | $583.00 K(-86.9%) |
| Dec 2023 | $4.44 M(+34.9%) | $4.44 M(+73.2%) |
| Sept 2023 | - | $2.56 M(+8.0%) |
| June 2023 | - | $2.37 M(-16.0%) |
| Mar 2023 | - | $2.83 M(-14.1%) |
| Dec 2022 | $3.29 M(+48.0%) | $3.29 M(+6.2%) |
| Sept 2022 | - | $3.10 M(-32.6%) |
| June 2022 | - | $4.60 M(-35.9%) |
| Mar 2022 | - | $7.17 M(+222.6%) |
| Dec 2021 | $2.22 M(-31.8%) | $2.22 M(-64.8%) |
| Sept 2021 | - | $6.32 M(+14.6%) |
| June 2021 | - | $5.52 M(-3.9%) |
| Mar 2021 | - | $5.74 M(+76.1%) |
| Dec 2020 | $3.26 M(-36.2%) | $3.26 M(+20.9%) |
| Sept 2020 | - | $2.70 M(+47.8%) |
| June 2020 | - | $1.82 M(-66.5%) |
| Mar 2020 | - | $5.45 M(+6.6%) |
| Dec 2019 | $5.11 M(+428.2%) | $5.11 M(+5.9%) |
| Sept 2019 | - | $4.83 M(+107.9%) |
| June 2019 | - | $2.32 M(+67.8%) |
| Mar 2019 | - | $1.38 M(+42.9%) |
| Dec 2018 | $968.00 K(-53.6%) | $968.00 K(-44.4%) |
| Sept 2018 | - | $1.74 M(-16.7%) |
| June 2018 | - | $2.09 M(+32.1%) |
| Mar 2018 | - | $1.58 M(-24.2%) |
| Dec 2017 | $2.09 M(+96.1%) | $2.09 M(+73.4%) |
| Sept 2017 | - | $1.20 M(+1.7%) |
| June 2017 | - | $1.18 M(+5.7%) |
| Mar 2017 | - | $1.12 M(+5.2%) |
| Dec 2016 | $1.06 M(+20.4%) | $1.06 M(+15.9%) |
| Sept 2016 | - | $918.90 K(-2.8%) |
| June 2016 | - | $945.80 K(+20.7%) |
| Mar 2016 | - | $783.30 K(-11.4%) |
| Dec 2015 | $884.10 K(+17.2%) | $884.10 K(+10.3%) |
| Sept 2015 | - | $801.30 K(-17.3%) |
| June 2015 | - | $969.00 K(-2.6%) |
| Mar 2015 | - | $994.90 K(+31.8%) |
| Dec 2014 | $754.60 K(+87.5%) | $754.60 K(+25.7%) |
| Sept 2014 | - | $600.20 K(+4.7%) |
| June 2014 | - | $573.50 K(-3.1%) |
| Mar 2014 | - | $591.70 K(+47.0%) |
| Dec 2013 | $402.50 K(-20.3%) | $402.50 K(+14.2%) |
| Sept 2013 | - | $352.30 K(-41.2%) |
| June 2013 | - | $599.00 K(-7.7%) |
| Mar 2013 | - | $648.90 K(+28.5%) |
| Dec 2012 | $504.90 K(+11.4%) | $504.90 K(+4.2%) |
| Sept 2012 | - | $484.50 K(-16.0%) |
| June 2012 | - | $576.90 K(-22.4%) |
| Mar 2012 | - | $743.90 K(+64.1%) |
| Dec 2011 | $453.30 K(-66.4%) | $453.30 K(-7.8%) |
| Sept 2011 | - | $491.90 K(-49.8%) |
| June 2011 | - | $980.70 K(-29.8%) |
| Mar 2011 | - | $1.40 M(+3.5%) |
| Dec 2010 | $1.35 M | $1.35 M(+0.0%) |
| Sept 2010 | - | $1.35 M(+4.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $1.29 M(-20.8%) |
| Mar 2010 | - | $1.63 M(-17.3%) |
| Dec 2009 | $1.97 M(-43.7%) | $1.97 M(-81.4%) |
| Sept 2009 | - | $10.56 M(+7.0%) |
| June 2009 | - | $9.87 M(-2.3%) |
| Mar 2009 | - | $10.11 M(+189.1%) |
| Dec 2008 | $3.50 M(-23.2%) | $3.50 M(-12.4%) |
| Sept 2008 | - | $3.99 M(-12.6%) |
| June 2008 | - | $4.56 M(-8.2%) |
| Mar 2008 | - | $4.97 M(+9.3%) |
| Dec 2007 | $4.55 M(-23.5%) | $4.55 M(-4.0%) |
| Sept 2007 | - | $4.74 M(-10.8%) |
| June 2007 | - | $5.31 M(-3.8%) |
| Mar 2007 | - | $5.52 M(-7.2%) |
| Dec 2006 | $5.95 M(+8.4%) | $5.95 M(+59.3%) |
| Sept 2006 | - | $3.73 M(+36.0%) |
| June 2006 | - | $2.74 M(-8.1%) |
| Mar 2006 | - | $2.99 M(-45.6%) |
| Dec 2005 | $5.49 M(+253.9%) | $5.49 M(+66.1%) |
| Sept 2005 | - | $3.30 M(+72.9%) |
| June 2005 | - | $1.91 M(-16.8%) |
| Mar 2005 | - | $2.29 M(+48.0%) |
| Dec 2004 | $1.55 M(-60.8%) | $1.55 M(+42.7%) |
| Sept 2004 | - | $1.09 M(-8.2%) |
| June 2004 | - | $1.18 M(-31.4%) |
| Mar 2004 | - | $1.73 M(-56.3%) |
| Dec 2003 | $3.95 M(-60.7%) | $3.95 M(+84.2%) |
| Sept 2003 | - | $2.15 M(-2.6%) |
| June 2003 | - | $2.20 M(-56.4%) |
| Mar 2003 | - | $5.05 M(-49.8%) |
| Dec 2002 | $10.07 M(-38.3%) | $10.07 M(+14.5%) |
| Sept 2002 | - | $8.79 M(+80.7%) |
| June 2002 | - | $4.86 M(-52.2%) |
| Mar 2002 | - | $10.17 M(-37.6%) |
| Dec 2001 | $16.31 M(+90.5%) | $16.31 M(+14.7%) |
| Sept 2001 | - | $14.22 M(+42.4%) |
| June 2001 | - | $9.99 M(+18.1%) |
| Mar 2001 | - | $8.46 M(-1.2%) |
| Dec 2000 | $8.56 M(+75.2%) | $8.56 M(+85.6%) |
| Sept 2000 | - | $4.61 M(+1.5%) |
| June 2000 | - | $4.55 M(+29.7%) |
| Mar 2000 | - | $3.51 M(-28.3%) |
| Dec 1999 | $4.89 M(+132.7%) | $4.89 M(+28.6%) |
| Sept 1999 | - | $3.80 M(+8.6%) |
| June 1999 | - | $3.50 M(+6.1%) |
| Mar 1999 | - | $3.30 M(+57.1%) |
| Dec 1998 | $2.10 M(+200.0%) | $2.10 M(+90.9%) |
| Sept 1998 | - | $1.10 M(+57.1%) |
| June 1998 | - | $700.00 K(-30.0%) |
| Mar 1998 | - | $1.00 M(+42.9%) |
| Dec 1997 | $700.00 K(+16.7%) | $700.00 K(+40.0%) |
| Sept 1997 | - | $500.00 K(-37.5%) |
| June 1997 | - | $800.00 K(+60.0%) |
| Mar 1997 | - | $500.00 K(-16.7%) |
| Dec 1996 | $600.00 K | $600.00 K(-57.1%) |
| Sept 1996 | - | $1.40 M(+75.0%) |
| June 1996 | - | $800.00 K(-42.9%) |
| Mar 1996 | - | $1.40 M |
FAQ
- What is CASI Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual accounts payable year-on-year change?
- What is CASI Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly accounts payable year-on-year change?
What is CASI Pharmaceuticals annual accounts payable?
The current annual accounts payable of CASI is $4.44 M
What is the all time high annual accounts payable for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual accounts payable is $16.31 M
What is CASI Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, CASI annual accounts payable has changed by +$1.15 M (+34.93%)
What is CASI Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of CASI is $1.76 M
What is the all time high quarterly accounts payable for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly accounts payable is $16.31 M
What is CASI Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, CASI quarterly accounts payable has changed by -$2.67 M (-60.25%)